PM(2.5) Exposure Inhibits Transepithelial Anion Short-circuit Current by Downregulating P2Y2 Receptor/CFTR Pathway.

Homo sapiensMus musculus ATPfine respirable suspended particulate mattersuramin

Study subjects

soma:liu-p2y2-calu3-001

Calu-3 submerged monolayer on transwell insert

type: CellularSystem Homo sapiens NCBITaxon:9606 bronchial epithelial cell CL:0002328
SUBJECT:liu-p2y2-mouse-control

Saline control male Balb/c mouse

type: InVivoSubject Mus musculus NCBITaxon:10090 sex: male

6-8 weeks old, 18-22 g, SPF grade, saline control group

SUBJECT:liu-p2y2-mouse-ova-pm25

OVA plus PM2.5 male Balb/c mouse

type: InVivoSubject Mus musculus NCBITaxon:10090 sex: male

6-8 weeks old, 18-22 g, SPF grade, OVA+PM2.5 group

soma:liu-p2y2-calu3-six-well-001

Calu-3 cells in six-well plates

type: CellularSystem Homo sapiens NCBITaxon:9606 bronchial epithelial cell CL:0002328
SUBJECT:liu-p2y2-mouse-cohort

Male Balb/c mouse cohort, five treatment groups

type: InVivoSubject Mus musculus NCBITaxon:10090 sex: male

6-8 weeks old, 18-22 g, SPF grade, 50 mice in five groups of 10

ASL assays

ASL:liu-p2y2-asl-calu3-24h

ASL volume after 24 h ATP and/or PM2.5, Calu-3 transwell

ASL volume recovered from the apical chamber after 24 h in four groups: PBS control, ATP 10 uM, PM2.5 100 ug/mL and ATP+PM2.5. Reported directions: ASL volume in the ATP group was higher than in the blank control group (p < 0.001), and ASL in the ATP+PM2.5 group was evidently lower than in the ATP group; the authors conclude that PM2.5 reduced ASL production. Transepithelial resistance was measured on the same monolayers: no difference between ATP and control, TER in the PM2.5 group lower than control, and TER in PM2.5+ATP significantly lower than in ATP alone. No numeric volumes or resistances are reported - only figure bars - so no magnitude is recorded here, and the schema has no slot for ASL volume (as opposed to height) or for TER.

Exposure conditions

ConditionAgentConcentrationDuration
PBS vehicle, 100 uL apical, 24 h
EXPOSURE:liu-p2y2-pbs-vehicle-24h
— — 24 hour
ATP 10 uM, 24 h
EXPOSURE:liu-p2y2-atp-10um-24h
ATP
CHEBI:15422
10 micromolar 24 hour
PM2.5 100 ug/mL, 24 h
EXPOSURE:liu-p2y2-pm25-100ug-24h
fine respirable suspended particulate matter
ENVO:01000415
100 microgram per milliliter 24 hour
ATP 10 uM plus PM2.5 100 ug/mL, 24 h
EXPOSURE:liu-p2y2-atp-pm25-24h
fine respirable suspended particulate matter
ENVO:01000415
100 microgram per milliliter 24 hour

Outputs

GroupOutputDescription
vehicle_control ASL volume, PBS control
ASL:liu-p2y2-asl-calu3-24h-output-control · under EXPOSURE:liu-p2y2-pbs-vehicle-24h
Baseline ASL volume. Reported as a figure bar only; no numeric value is given in the paper.
treated ASL volume, ATP 10 uM
ASL:liu-p2y2-asl-calu3-24h-output-atp · under EXPOSURE:liu-p2y2-atp-10um-24h
Higher than the blank control group (p < 0.001). Figure bar only; no numeric value is given in the paper.
treated ASL volume, PM2.5 100 ug/mL
ASL:liu-p2y2-asl-calu3-24h-output-pm25 · under EXPOSURE:liu-p2y2-pm25-100ug-24h
PM2.5 treatment reduced ASL production. Figure bar only; no numeric value is given in the paper.
treated ASL volume, ATP + PM2.5
ASL:liu-p2y2-asl-calu3-24h-output-atp-pm25 · under EXPOSURE:liu-p2y2-atp-pm25-24h
Evidently lower than the ATP group. Figure bar only; no numeric value is given in the paper.

Evidence

In the transwell model, the volume of ASL in the ATP group was higher than that in the blank control group (p < 0.001).
SUPPORT IN VITRO PMID:39113893

Establishes the ATP-stimulated baseline against which the PM2.5 and ATP+PM2.5 groups of this assay are compared.

These results indicated that PM2.5treatment reduced the ASL production in airway epithelial cells.
SUPPORT IN VITRO PMID:39113893

The authors' own summary of this assay: PM2.5 reduced ASL production, the decrease this assay records.

CFTR assays

CFTR:liu-p2y2-isc-calu3-24h

ATP-induced transepithelial anion Isc, Calu-3 control vs PM2.5, 24 h

Isc measured in an Ussing chamber. A stable baseline with no Isc peak was seen in both the control and the PM2.5 group before stimulation; adding ATP 10 uM to side A produced a rapidly rising Isc peak in both. The increase in the ATP-induced Isc peak (delta-Isc) in the PM2.5 group was significantly slower than in the control group (p < 0.05), and the average rate (delta-Isc/delta-T) evidently decreased in the PM2.5 group. The paper reports these as figure traces and bars with a significance threshold only, so no current magnitudes are recorded here.

stimulation agent: ATP 10 uM, added to side A (luminal)

Exposure conditions

ConditionAgentConcentrationDuration
PBS vehicle, 100 uL apical, 24 h
EXPOSURE:liu-p2y2-pbs-vehicle-24h
— — 24 hour
PM2.5 100 ug/mL, 24 h
EXPOSURE:liu-p2y2-pm25-100ug-24h
fine respirable suspended particulate matter
ENVO:01000415
100 microgram per milliliter 24 hour

Outputs

GroupOutputDescription
vehicle_control ATP-induced Isc, control monolayer
CFTR:liu-p2y2-isc-calu3-24h-output-control · under EXPOSURE:liu-p2y2-pbs-vehicle-24h
Stable baseline with no Isc peak before ATP, then a rapidly rising ATP-induced Isc peak. Reported as a figure trace; the paper gives no numeric current or rate.
treated ATP-induced Isc, PM2.5-exposed monolayer
CFTR:liu-p2y2-isc-calu3-24h-output-pm25 · under EXPOSURE:liu-p2y2-pm25-100ug-24h
ATP-induced Isc peak rose significantly more slowly than control (p < 0.05) and the average rate delta-Isc/delta-T evidently decreased. Reported as a figure trace and bar; the paper gives no numeric current or rate.

Evidence

In transwell model, the adenosine triphosphate (ATP)-induced transepithelial anion short-circuit current (Isc) and airway surface liquid (ASL) significantly decreased after PM2.5 exposure.
SUPPORT IN VITRO PMID:39113893

The paper's abstract statement of this assay's result: the ATP-induced Isc fell after PM2.5 exposure.

Obviously, compared with the control group, the average rate (∆Isc/∆T) of Iscchanges evidently decreased in the PM2.5group
SUPPORT IN VITRO PMID:39113893

Gives the specific quantity that decreased in the PM2.5 output of this assay - the average rate of Isc change from baseline to peak.

CFTR:liu-p2y2-isc-trachea-control

ATP-induced transepithelial anion Isc, control mouse trachea

Isc in freshly excised main tracheal tissue (8 mm x 8 mm) from saline control mice, stimulated with ATP 100 uM on the luminal side. A stable baseline and an ATP-induced Isc peak were recorded. Control and PM2.5 tracheal recordings come from different animals, so they are kept as separate assay records. The paper reports traces and bars only; no numeric current or rate is given.

stimulation agent: ATP 100 uM, added to the luminal side

Exposure conditions

ConditionAgentConcentrationDuration
Saline control: intraperitoneal injection and inhalation of an equal volume of saline, no nasal instillation
EXPOSURE:liu-p2y2-mouse-saline-control
— — —

Outputs

GroupOutputDescription
control ATP-induced Isc, control mouse trachea
CFTR:liu-p2y2-isc-trachea-control-output · under EXPOSURE:liu-p2y2-mouse-saline-control
Baseline Isc and ATP-induced Isc peak in control tracheal tissue. Figure trace only; no numeric value is given in the paper.

Evidence

Similarly, these findings could be obtained from the trachea tissue of mice
SUPPORT MODEL ORGANISM PMID:39113893

States that the tracheal-tissue experiment reproduced the Calu-3 result, which is what this control recording and its PM2.5 counterpart together show.

CFTR:liu-p2y2-isc-trachea-pm25

ATP-induced transepithelial anion Isc, PM2.5-exposed mouse trachea

Isc in main tracheal tissue from OVA mice given nasal instillation of PM2.5 on days 21-27, stimulated with ATP 100 uM on the luminal side. PM2.5 exposure inhibited the ATP-induced transepithelial Isc of tracheal tissue relative to control (Student's t test, p < 0.05, reported in the figure). The paper reports traces and bars only; no numeric current or rate is given.

stimulation agent: ATP 100 uM, added to the luminal side

Exposure conditions

ConditionAgentConcentrationDuration
OVA sensitisation and challenge plus PM2.5 100 ug/mL nasal instillation, days 21-27
EXPOSURE:liu-p2y2-mouse-ova-pm25
fine respirable suspended particulate matter
ENVO:01000415
100 microgram per milliliter 7 day

Outputs

GroupOutputDescription
treated ATP-induced Isc, PM2.5-exposed mouse trachea
CFTR:liu-p2y2-isc-trachea-pm25-output · under EXPOSURE:liu-p2y2-mouse-ova-pm25
ATP-induced Isc inhibited relative to the control trachea. Figure trace and bar only; no numeric value is given in the paper.

Evidence

PM2.5exposure similarly inhibited the ATP-induced transepithelial Iscof tracheal tissue.
SUPPORT MODEL ORGANISM PMID:39113893

States directly the in vivo result this assay records: PM2.5 inhibited the ATP-induced Isc of tracheal tissue.

Gene expression assays

GE:liu-p2y2-p2y2r-mrna-24h

P2Y2R mRNA in Calu-3 cells at 24 h (qRT-PCR)

P2Y2R mRNA measured by qRT-PCR with GADPH as internal control in six groups (control, ATP 10 uM, PM2.5 100 ug/mL, Suramin 100 uM, ATP+PM2.5, Suramin+PM2.5) after 24 h. At 24 h there was no difference between the ATP group and the control group (p > 0.05). The paper reports relative expression as figure bars only; no numeric fold changes are given.

target gene: PR:P41231 gene expression method: qRT-PCR normalization reference: GADPH

Exposure conditions

ConditionAgentConcentrationDuration
PBS vehicle, 100 uL apical, 24 h
EXPOSURE:liu-p2y2-pbs-vehicle-24h
— — 24 hour
ATP 10 uM, 24 h
EXPOSURE:liu-p2y2-atp-10um-24h
ATP
CHEBI:15422
10 micromolar 24 hour
PM2.5 100 ug/mL, 24 h
EXPOSURE:liu-p2y2-pm25-100ug-24h
fine respirable suspended particulate matter
ENVO:01000415
100 microgram per milliliter 24 hour

Outputs

GroupOutputDescription
vehicle_control P2Y2R mRNA at 24 h, control
GE:liu-p2y2-p2y2r-mrna-24h-output-control · under EXPOSURE:liu-p2y2-pbs-vehicle-24h
Reference group. Figure bar only; no numeric value is given in the paper.
treated P2Y2R mRNA at 24 h, ATP 10 uM
GE:liu-p2y2-p2y2r-mrna-24h-output-atp · under EXPOSURE:liu-p2y2-atp-10um-24h
No difference from control at 24 h (p > 0.05). Figure bar only; no numeric value is given in the paper.
treated P2Y2R mRNA at 24 h, PM2.5 100 ug/mL
GE:liu-p2y2-p2y2r-mrna-24h-output-pm25 · under EXPOSURE:liu-p2y2-pm25-100ug-24h
Figure bar only; no numeric value is given in the paper.

Evidence

the expression levels ofP2Y2RmRNA had no difference between ATP group and control group at 24 h (p > 0.05)
SUPPORT IN VITRO PMID:39113893

The 24 h timepoint result this assay records: ATP had not yet raised P2Y2R mRNA above control.

GE:liu-p2y2-p2y2r-mrna-48h

P2Y2R mRNA in Calu-3 cells at 48 h (qRT-PCR)

P2Y2R mRNA at 48 h. Reported directions: P2Y2R in the ATP group was evidently higher than control; P2Y2R in the ATP+PM2.5 group was significantly lower than in the ATP group; and P2Y2R was lower in the PM2.5+Suramin group than in the Suramin group. The paper reports relative expression as figure bars only; no numeric fold changes are given.

target gene: PR:P41231 gene expression method: qRT-PCR normalization reference: GADPH

Exposure conditions

ConditionAgentConcentrationDuration
PBS vehicle, 48 h
EXPOSURE:liu-p2y2-pbs-vehicle-48h
— — 48 hour
ATP 10 uM, 48 h
EXPOSURE:liu-p2y2-atp-10um-48h
ATP
CHEBI:15422
10 micromolar 48 hour
ATP 10 uM plus PM2.5 100 ug/mL, 48 h
EXPOSURE:liu-p2y2-atp-pm25-48h
fine respirable suspended particulate matter
ENVO:01000415
100 microgram per milliliter 48 hour
Suramin 100 uM, 48 h
EXPOSURE:liu-p2y2-suramin-100um-48h
suramin
CHEBI:45906
100 micromolar 48 hour
Suramin 100 uM plus PM2.5 100 ug/mL, 48 h
EXPOSURE:liu-p2y2-suramin-pm25-48h
fine respirable suspended particulate matter
ENVO:01000415
100 microgram per milliliter 48 hour

Outputs

GroupOutputDescription
vehicle_control P2Y2R mRNA at 48 h, control
GE:liu-p2y2-p2y2r-mrna-48h-output-control · under EXPOSURE:liu-p2y2-pbs-vehicle-48h
Reference group. Figure bar only; no numeric value is given in the paper.
treated P2Y2R mRNA at 48 h, ATP 10 uM
GE:liu-p2y2-p2y2r-mrna-48h-output-atp · under EXPOSURE:liu-p2y2-atp-10um-48h
Evidently higher than control at 48 h. Figure bar only; no numeric value is given in the paper.
treated P2Y2R mRNA at 48 h, ATP + PM2.5
GE:liu-p2y2-p2y2r-mrna-48h-output-atp-pm25 · under EXPOSURE:liu-p2y2-atp-pm25-48h
Significantly lower than the ATP group. Figure bar only; no numeric value is given in the paper.
treated P2Y2R mRNA at 48 h, Suramin 100 uM
GE:liu-p2y2-p2y2r-mrna-48h-output-suramin · under EXPOSURE:liu-p2y2-suramin-100um-48h
P2Y2R antagonist group. Figure bar only; no numeric value is given in the paper.
treated P2Y2R mRNA at 48 h, Suramin + PM2.5
GE:liu-p2y2-p2y2r-mrna-48h-output-suramin-pm25 · under EXPOSURE:liu-p2y2-suramin-pm25-48h
Lower than the Suramin group. Figure bar only; no numeric value is given in the paper.

Evidence

The expression levels ofP2Y2Rin the ATP+PM2.5group were significantly lower than that in the ATP group.
SUPPORT IN VITRO PMID:39113893

The 48 h result this assay records: PM2.5 suppressed the ATP-driven rise in P2Y2R mRNA.

The expression levels of P2Y2R were lower in the PM2.5+Suramin group than that in the Suramin group
SUPPORT IN VITRO PMID:39113893

Supports the Suramin+PM2.5 output of this assay: PM2.5 lowered P2Y2R further than the antagonist alone.

GE:liu-p2y2-p2y2r-protein-wb

P2Y2R protein in Calu-3 cells at 24 h and 48 h (western blot)

P2Y2R protein by western blot with GADPH loading control, semi-quantified by densitometry. Reported directions: P2Y2R in the Suramin group and the PM2.5 group was significantly lower than control at both 24 h and 48 h (p < 0.05); P2Y2R in the ATP group was elevated relative to control after 48 h (p < 0.05); P2Y2R in the ATP+PM2.5 group was significantly lower than in the ATP group at both timepoints (p < 0.01); and P2Y2R in the PM2.5+Suramin group was obviously lower than in the Suramin group. The paper reports densitometry as figure bars only; no numeric values are given.

target gene: PR:P41231 gene expression method: Western blot normalization reference: GADPH

Exposure conditions

ConditionAgentConcentrationDuration
PBS vehicle, 100 uL apical, 24 h
EXPOSURE:liu-p2y2-pbs-vehicle-24h
— — 24 hour
PM2.5 100 ug/mL, 24 h
EXPOSURE:liu-p2y2-pm25-100ug-24h
fine respirable suspended particulate matter
ENVO:01000415
100 microgram per milliliter 24 hour
ATP 10 uM plus PM2.5 100 ug/mL, 24 h
EXPOSURE:liu-p2y2-atp-pm25-24h
fine respirable suspended particulate matter
ENVO:01000415
100 microgram per milliliter 24 hour
Suramin 100 uM, 24 h
EXPOSURE:liu-p2y2-suramin-100um-24h
suramin
CHEBI:45906
100 micromolar 24 hour

Outputs

GroupOutputDescription
vehicle_control P2Y2R protein, control
GE:liu-p2y2-p2y2r-protein-wb-output-control · under EXPOSURE:liu-p2y2-pbs-vehicle-24h
Reference group. Figure bar only; no numeric densitometry value is given in the paper.
treated P2Y2R protein, PM2.5 100 ug/mL
GE:liu-p2y2-p2y2r-protein-wb-output-pm25 · under EXPOSURE:liu-p2y2-pm25-100ug-24h
Significantly lower than control at 24 h and 48 h (p < 0.05). Figure bar only; no numeric densitometry value is given in the paper.
treated P2Y2R protein, ATP + PM2.5
GE:liu-p2y2-p2y2r-protein-wb-output-atp-pm25 · under EXPOSURE:liu-p2y2-atp-pm25-24h
Significantly lower than the ATP group at 24 h and 48 h (p < 0.01). Figure bar only; no numeric densitometry value is given in the paper.
treated P2Y2R protein, Suramin 100 uM
GE:liu-p2y2-p2y2r-protein-wb-output-suramin · under EXPOSURE:liu-p2y2-suramin-100um-24h
Significantly lower than control at 24 h and 48 h (p < 0.05). Figure bar only; no numeric densitometry value is given in the paper.

Evidence

In vitro, western blot indicated that the expression levels of P2Y2R and CFTR significantly decreased after PM2.5exposure.
SUPPORT IN VITRO PMID:39113893

States the decrease in P2Y2R protein after PM2.5 that this assay's PM2.5 output records.

The expression levels of P2Y2R and CFTR in the Suramin group and PM2.5group were significantly lower than these in the control group after 24 h and 48 h (p < 0.05)
SUPPORT IN VITRO PMID:39113893

Gives the comparison, timepoints and significance threshold behind the Suramin and PM2.5 outputs of this assay.

GE:liu-p2y2-cftr-protein-wb

CFTR protein in Calu-3 cells at 24 h and 48 h (western blot)

CFTR protein by western blot with GADPH loading control, semi-quantified by densitometry, in the same blots as P2Y2R. Reported directions: CFTR in the Suramin group and the PM2.5 group was significantly lower than control at 24 h and 48 h (p < 0.05); CFTR in the ATP group was elevated relative to control after 48 h (p < 0.05); and CFTR in the ATP+PM2.5 group was significantly lower than in the ATP group at both timepoints (p < 0.01). The paper reports densitometry as figure bars only; no numeric values are given.

target gene: PR:P13569 gene expression method: Western blot normalization reference: GADPH

Exposure conditions

ConditionAgentConcentrationDuration
PBS vehicle, 100 uL apical, 24 h
EXPOSURE:liu-p2y2-pbs-vehicle-24h
— — 24 hour
PM2.5 100 ug/mL, 24 h
EXPOSURE:liu-p2y2-pm25-100ug-24h
fine respirable suspended particulate matter
ENVO:01000415
100 microgram per milliliter 24 hour
ATP 10 uM plus PM2.5 100 ug/mL, 24 h
EXPOSURE:liu-p2y2-atp-pm25-24h
fine respirable suspended particulate matter
ENVO:01000415
100 microgram per milliliter 24 hour
Suramin 100 uM, 24 h
EXPOSURE:liu-p2y2-suramin-100um-24h
suramin
CHEBI:45906
100 micromolar 24 hour

Outputs

GroupOutputDescription
vehicle_control CFTR protein, control
GE:liu-p2y2-cftr-protein-wb-output-control · under EXPOSURE:liu-p2y2-pbs-vehicle-24h
Reference group. Figure bar only; no numeric densitometry value is given in the paper.
treated CFTR protein, PM2.5 100 ug/mL
GE:liu-p2y2-cftr-protein-wb-output-pm25 · under EXPOSURE:liu-p2y2-pm25-100ug-24h
Significantly lower than control at 24 h and 48 h (p < 0.05). Figure bar only; no numeric densitometry value is given in the paper.
treated CFTR protein, ATP + PM2.5
GE:liu-p2y2-cftr-protein-wb-output-atp-pm25 · under EXPOSURE:liu-p2y2-atp-pm25-24h
Significantly lower than the ATP group at 24 h and 48 h (p < 0.01). Figure bar only; no numeric densitometry value is given in the paper.
treated CFTR protein, Suramin 100 uM
GE:liu-p2y2-cftr-protein-wb-output-suramin · under EXPOSURE:liu-p2y2-suramin-100um-24h
Significantly lower than control at 24 h and 48 h (p < 0.05). Figure bar only; no numeric densitometry value is given in the paper.

Evidence

In vitro, western blot indicated that the expression levels of P2Y2R and CFTR significantly decreased after PM2.5exposure.
SUPPORT IN VITRO PMID:39113893

States the decrease in CFTR protein after PM2.5 that this assay's PM2.5 output records.

the expression levels of P2Y2R and CFTR in ATP+PM2.5group were significantly lower than that in the ATP group after 24 h and 48 h (p < 0.01)
SUPPORT IN VITRO PMID:39113893

Gives the comparison, timepoints and significance threshold behind this assay's ATP+PM2.5 output.

GE:liu-p2y2-p2y2r-ihc-lung

P2Y2R protein in mouse lung tissue (immunohistochemistry)

P2Y2R immunohistochemistry on 5 um paraffin sections of left lung, expressed as the percentage of positive cells / positive area. Reported directions: P2Y2R dramatically decreased in the OVA group relative to control; the OVA+PM2.5 group was significantly lower than the OVA group; and the OVA+ATP group significantly increased relative to the OVA group. The paper reports positive-area percentages as figure bars only; no numeric percentages are given.

target gene: PR:P41231 gene expression method: immunohistochemistry normalization reference: positive area as a percentage of the analysed section

Exposure conditions

ConditionAgentConcentrationDuration
Saline control: intraperitoneal injection and inhalation of an equal volume of saline, no nasal instillation
EXPOSURE:liu-p2y2-mouse-saline-control
— — —
OVA sensitisation and challenge alone, no nasal instillation
EXPOSURE:liu-p2y2-mouse-ova
— — —
OVA sensitisation and challenge plus PM2.5 100 ug/mL nasal instillation, days 21-27
EXPOSURE:liu-p2y2-mouse-ova-pm25
fine respirable suspended particulate matter
ENVO:01000415
100 microgram per milliliter 7 day
OVA sensitisation and challenge plus ATP 50 mg/kg nasal instillation, days 21-27
EXPOSURE:liu-p2y2-mouse-ova-atp
ATP
CHEBI:15422
50 milligram per kilogram 7 day

Outputs

GroupOutputDescription
control P2Y2R positive area, saline control lung
GE:liu-p2y2-p2y2r-ihc-lung-output-control · under EXPOSURE:liu-p2y2-mouse-saline-control
Reference group. Figure bar only; no numeric percentage is given in the paper.
treated P2Y2R positive area, OVA lung
GE:liu-p2y2-p2y2r-ihc-lung-output-ova · under EXPOSURE:liu-p2y2-mouse-ova
Dramatically decreased relative to control. Figure bar only; no numeric percentage is given in the paper.
treated P2Y2R positive area, OVA + PM2.5 lung
GE:liu-p2y2-p2y2r-ihc-lung-output-ova-pm25 · under EXPOSURE:liu-p2y2-mouse-ova-pm25
Significantly lower than the OVA group. Figure bar only; no numeric percentage is given in the paper.
treated P2Y2R positive area, OVA + ATP lung
GE:liu-p2y2-p2y2r-ihc-lung-output-ova-atp · under EXPOSURE:liu-p2y2-mouse-ova-atp
Significantly increased relative to the OVA group. Figure bar only; no numeric percentage is given in the paper.

Evidence

Compared with control group, the expression levels of P2Y2R and CFTR in the OVA group dramatically decreased.
SUPPORT MODEL ORGANISM PMID:39113893

Supports the OVA output of this assay: P2Y2R staining fell in asthmatic lung relative to saline control.

Furthermore, the expression levels of P2Y2R and CFTR in the PM2.5group were significantly lower than these in the OVA group.
SUPPORT MODEL ORGANISM PMID:39113893

Supports the OVA+PM2.5 output of this assay: PM2.5 lowered P2Y2R further than OVA alone.

GE:liu-p2y2-cftr-ihc-lung

CFTR protein in mouse lung tissue (immunohistochemistry)

CFTR immunohistochemistry on the same lung sections, expressed as the percentage of positive cells / positive area, with western blot of right lung tissue in parallel. Reported directions: CFTR dramatically decreased in the OVA group relative to control; the OVA+PM2.5 group was significantly lower than the OVA group; and the OVA+ATP group significantly increased relative to the OVA group. The paper reports positive-area percentages as figure bars only; no numeric percentages are given.

target gene: PR:P13569 gene expression method: immunohistochemistry normalization reference: positive area as a percentage of the analysed section

Exposure conditions

ConditionAgentConcentrationDuration
Saline control: intraperitoneal injection and inhalation of an equal volume of saline, no nasal instillation
EXPOSURE:liu-p2y2-mouse-saline-control
— — —
OVA sensitisation and challenge alone, no nasal instillation
EXPOSURE:liu-p2y2-mouse-ova
— — —
OVA sensitisation and challenge plus PM2.5 100 ug/mL nasal instillation, days 21-27
EXPOSURE:liu-p2y2-mouse-ova-pm25
fine respirable suspended particulate matter
ENVO:01000415
100 microgram per milliliter 7 day
OVA sensitisation and challenge plus ATP 50 mg/kg nasal instillation, days 21-27
EXPOSURE:liu-p2y2-mouse-ova-atp
ATP
CHEBI:15422
50 milligram per kilogram 7 day

Outputs

GroupOutputDescription
control CFTR positive area, saline control lung
GE:liu-p2y2-cftr-ihc-lung-output-control · under EXPOSURE:liu-p2y2-mouse-saline-control
Reference group. Figure bar only; no numeric percentage is given in the paper.
treated CFTR positive area, OVA lung
GE:liu-p2y2-cftr-ihc-lung-output-ova · under EXPOSURE:liu-p2y2-mouse-ova
Dramatically decreased relative to control. Figure bar only; no numeric percentage is given in the paper.
treated CFTR positive area, OVA + PM2.5 lung
GE:liu-p2y2-cftr-ihc-lung-output-ova-pm25 · under EXPOSURE:liu-p2y2-mouse-ova-pm25
Significantly lower than the OVA group. Figure bar only; no numeric percentage is given in the paper.
treated CFTR positive area, OVA + ATP lung
GE:liu-p2y2-cftr-ihc-lung-output-ova-atp · under EXPOSURE:liu-p2y2-mouse-ova-atp
Significantly increased relative to the OVA group. Figure bar only; no numeric percentage is given in the paper.

Evidence

Furthermore, the expression levels of P2Y2R and CFTR in the PM2.5group were significantly lower than these in the OVA group.
SUPPORT MODEL ORGANISM PMID:39113893

Supports the OVA+PM2.5 output of this assay: CFTR staining in lung fell below the OVA group.

Goblet cell assays

GCM:liu-p2y2-pas-bronchus

Goblet cell proportion in mouse bronchus (PAS staining)

PAS-positive cells counted as goblet cells on 5 um sections; goblet cells were mainly distributed near the trachea and bronchus. Reported directions: the proportion of goblet cells was significantly higher in OVA mice than in the blank group; the proportion in ATP-treated OVA mice was evidently lower than in the OVA group; and the proportion in the PM2.5 group and the Suramin group was obviously higher than in the OVA group. Semi-quantification is reported as goblet cell positive percentage in a figure only; no numeric percentages are given.

Exposure conditions

ConditionAgentConcentrationDuration
Saline control: intraperitoneal injection and inhalation of an equal volume of saline, no nasal instillation
EXPOSURE:liu-p2y2-mouse-saline-control
— — —
OVA sensitisation and challenge alone, no nasal instillation
EXPOSURE:liu-p2y2-mouse-ova
— — —
OVA sensitisation and challenge plus PM2.5 100 ug/mL nasal instillation, days 21-27
EXPOSURE:liu-p2y2-mouse-ova-pm25
fine respirable suspended particulate matter
ENVO:01000415
100 microgram per milliliter 7 day
OVA sensitisation and challenge plus ATP 50 mg/kg nasal instillation, days 21-27
EXPOSURE:liu-p2y2-mouse-ova-atp
ATP
CHEBI:15422
50 milligram per kilogram 7 day
OVA sensitisation and challenge plus Suramin 50 mg/kg nasal instillation, days 21-27
EXPOSURE:liu-p2y2-mouse-ova-suramin
suramin
CHEBI:45906
50 milligram per kilogram 7 day

Outputs

GroupOutputDescription
control Goblet cell proportion, saline control
GCM:liu-p2y2-pas-bronchus-output-control · under EXPOSURE:liu-p2y2-mouse-saline-control
Blank group reference. Figure bar only; no numeric percentage is given in the paper.
treated Goblet cell proportion, OVA
GCM:liu-p2y2-pas-bronchus-output-ova · under EXPOSURE:liu-p2y2-mouse-ova
Significantly higher than the blank group. Figure bar only; no numeric percentage is given in the paper.
treated Goblet cell proportion, OVA + PM2.5
GCM:liu-p2y2-pas-bronchus-output-ova-pm25 · under EXPOSURE:liu-p2y2-mouse-ova-pm25
Obviously higher than the OVA group. Figure bar only; no numeric percentage is given in the paper.
treated Goblet cell proportion, OVA + ATP
GCM:liu-p2y2-pas-bronchus-output-ova-atp · under EXPOSURE:liu-p2y2-mouse-ova-atp
Evidently lower than the OVA group. Figure bar only; no numeric percentage is given in the paper.
treated Goblet cell proportion, OVA + Suramin
GCM:liu-p2y2-pas-bronchus-output-ova-suramin · under EXPOSURE:liu-p2y2-mouse-ova-suramin
Obviously higher than the OVA group. Figure bar only; no numeric percentage is given in the paper.

Evidence

the proportion of goblet cells in PM2.5group and Suramin group was obviously higher than that in OVA group
SUPPORT MODEL ORGANISM PMID:39113893

Supports the OVA+PM2.5 and OVA+Suramin outputs of this assay: both exceeded the OVA group.

The proportion of goblet cells in the ATP-treated OVA mice was evidently lower than that in the OVA group.
SUPPORT MODEL ORGANISM PMID:39113893

Supports the OVA+ATP output of this assay: P2Y2R agonism lowered goblet cell proportion below the OVA group.

BALF sputum assays

BALF:liu-p2y2-th2-cytokines

Th2 cytokines (IL-4, IL-5, IL-13) in mouse BALF (ELISA)

IL-4, IL-5 and IL-13 measured by ELISA in BALF from the right lung (left main bronchus ligated, right lung washed twice with 0.5 mL saline). Reported directions: all three were higher in the OVA group than in control; all three increased significantly in the OVA+PM2.5 group relative to OVA; all three were lower in the OVA+ATP group than in OVA; and IL-13 was higher in the OVA+Suramin group than in OVA. The paper reports concentrations as figure bars only and gives no numeric concentrations; the schema's BALF output class also has no IL-4, IL-5 or IL-13 slot, so these outputs carry their group and condition without a magnitude.

Exposure conditions

ConditionAgentConcentrationDuration
Saline control: intraperitoneal injection and inhalation of an equal volume of saline, no nasal instillation
EXPOSURE:liu-p2y2-mouse-saline-control
— — —
OVA sensitisation and challenge alone, no nasal instillation
EXPOSURE:liu-p2y2-mouse-ova
— — —
OVA sensitisation and challenge plus PM2.5 100 ug/mL nasal instillation, days 21-27
EXPOSURE:liu-p2y2-mouse-ova-pm25
fine respirable suspended particulate matter
ENVO:01000415
100 microgram per milliliter 7 day
OVA sensitisation and challenge plus ATP 50 mg/kg nasal instillation, days 21-27
EXPOSURE:liu-p2y2-mouse-ova-atp
ATP
CHEBI:15422
50 milligram per kilogram 7 day
OVA sensitisation and challenge plus Suramin 50 mg/kg nasal instillation, days 21-27
EXPOSURE:liu-p2y2-mouse-ova-suramin
suramin
CHEBI:45906
50 milligram per kilogram 7 day

Outputs

GroupOutputDescription
control BALF IL-4, IL-5, IL-13, saline control
BALF:liu-p2y2-th2-cytokines-output-control · under EXPOSURE:liu-p2y2-mouse-saline-control
Reference group. Figure bars only; no numeric concentrations are given in the paper.
treated BALF IL-4, IL-5, IL-13, OVA
BALF:liu-p2y2-th2-cytokines-output-ova · under EXPOSURE:liu-p2y2-mouse-ova
All three higher than control. Figure bars only; no numeric concentrations are given in the paper.
treated BALF IL-4, IL-5, IL-13, OVA + PM2.5
BALF:liu-p2y2-th2-cytokines-output-ova-pm25 · under EXPOSURE:liu-p2y2-mouse-ova-pm25
All three significantly increased relative to the OVA group. Figure bars only; no numeric concentrations are given in the paper.
treated BALF IL-4, IL-5, IL-13, OVA + ATP
BALF:liu-p2y2-th2-cytokines-output-ova-atp · under EXPOSURE:liu-p2y2-mouse-ova-atp
All three lower than the OVA group. Figure bars only; no numeric concentrations are given in the paper.
treated BALF IL-4, IL-5, IL-13, OVA + Suramin
BALF:liu-p2y2-th2-cytokines-output-ova-suramin · under EXPOSURE:liu-p2y2-mouse-ova-suramin
IL-13 higher than the OVA group. Figure bars only; no numeric concentrations are given in the paper.

Evidence

Compared with OVA group, the expression levels of IL-4, IL-5 and IL-13 in PM2.5group significantly increased.
SUPPORT MODEL ORGANISM PMID:39113893

Supports the OVA+PM2.5 output of this assay: the three Th2 cytokines rose above the OVA group.

PM2.5 exposure increased the levels of Th2-related cytokines of bronchoalveolar lavage fluid, lung inflammation, collagen deposition and hyperplasisa of goblet cells.
SUPPORT MODEL ORGANISM PMID:39113893

The abstract's statement of the same result, tying the BALF cytokine rise to the airway inflammation key event this assay informs.

Lung function assays

LF:liu-p2y2-sraw-methacholine

Special airway resistance (sRaw) under methacholine challenge

Whole-body plethysmography with methacholine aerosol at 0, 5, 10 and 20 mg/mL; airway responsiveness expressed as sRaw in cmH2O/mL/s. Reported directions: sRaw in OVA mice increased significantly over control, confirming the asthma model; sRaw in the OVA+PM2.5 group was significantly elevated over the OVA group; sRaw at 20 mg/mL methacholine in the OVA+Suramin group was higher than OVA alone (p < 0.05); and sRaw in the OVA+ATP group did not differ from OVA. The paper reports sRaw as figure curves only; no numeric resistances are given, so no magnitude is recorded here.

Exposure conditions

ConditionAgentConcentrationDuration
Saline control: intraperitoneal injection and inhalation of an equal volume of saline, no nasal instillation
EXPOSURE:liu-p2y2-mouse-saline-control
— — —
OVA sensitisation and challenge alone, no nasal instillation
EXPOSURE:liu-p2y2-mouse-ova
— — —
OVA sensitisation and challenge plus PM2.5 100 ug/mL nasal instillation, days 21-27
EXPOSURE:liu-p2y2-mouse-ova-pm25
fine respirable suspended particulate matter
ENVO:01000415
100 microgram per milliliter 7 day
OVA sensitisation and challenge plus ATP 50 mg/kg nasal instillation, days 21-27
EXPOSURE:liu-p2y2-mouse-ova-atp
ATP
CHEBI:15422
50 milligram per kilogram 7 day
OVA sensitisation and challenge plus Suramin 50 mg/kg nasal instillation, days 21-27
EXPOSURE:liu-p2y2-mouse-ova-suramin
suramin
CHEBI:45906
50 milligram per kilogram 7 day

Outputs

GroupOutputDescription
control sRaw, saline control
LF:liu-p2y2-sraw-methacholine-output-control · under EXPOSURE:liu-p2y2-mouse-saline-control
Control mice showed none of the restlessness or ragged breathing seen in OVA mice with rising methacholine. Figure curve only; no numeric sRaw is given in the paper.
treated sRaw, OVA
LF:liu-p2y2-sraw-methacholine-output-ova · under EXPOSURE:liu-p2y2-mouse-ova
Increased significantly over control, confirming the asthma model. Figure curve only; no numeric sRaw is given in the paper.
treated sRaw, OVA + PM2.5
LF:liu-p2y2-sraw-methacholine-output-ova-pm25 · under EXPOSURE:liu-p2y2-mouse-ova-pm25
Significantly elevated over the OVA group. Figure curve only; no numeric sRaw is given in the paper.
treated sRaw, OVA + ATP
LF:liu-p2y2-sraw-methacholine-output-ova-atp · under EXPOSURE:liu-p2y2-mouse-ova-atp
No difference from the OVA group. Figure curve only; no numeric sRaw is given in the paper.
treated sRaw, OVA + Suramin
LF:liu-p2y2-sraw-methacholine-output-ova-suramin · under EXPOSURE:liu-p2y2-mouse-ova-suramin
Higher than the OVA group at 20 mg/mL methacholine (p < 0.05). Figure curve only; no numeric sRaw is given in the paper.

Evidence

The sRaw value in PM2.5group was significantly elevated than that in the OVA group.
SUPPORT MODEL ORGANISM PMID:39113893

Supports the OVA+PM2.5 output of this assay: PM2.5 worsened airway resistance beyond OVA alone.

The sRaw value of methacholine inhalation at 20 mg/mL in the Suramin+OVA group was higher than that in the OVA group alone (P <0.05).
SUPPORT MODEL ORGANISM PMID:39113893

Supports the OVA+Suramin output of this assay and the paper's inference that P2Y2R blockade alone worsens airway responsiveness.

Response comparisons

COMP:liu-p2y2-isc-calu3-pm25-vs-control

ATP-induced Isc, PM2.5 vs control (Calu-3, 24 h)

The increase in the ATP-induced Isc peak was significantly slower in the PM2.5 group than in the control group, and the average rate delta-Isc/delta-T evidently decreased. Reported significance: p < 0.05 by one-way ANOVA. The paper gives no magnitude for the change.

measurement: cftr_chloride_secretion direction: decreased derivation: reported in paper from assay: CFTR:liu-p2y2-isc-calu3-24h

Statistical test: one-way analysis of variance

COMP:liu-p2y2-isc-trachea-pm25-vs-control

ATP-induced Isc, PM2.5 vs control (mouse trachea)

Cross-assay comparison: the control and PM2.5 tracheal recordings are separate assay records because they come from different animals. PM2.5 exposure inhibited the ATP-induced transepithelial Isc of tracheal tissue. Reported significance: p < 0.05 by Student's t test. The paper gives no magnitude for the change.

measurement: cftr_chloride_secretion direction: decreased derivation: reported in paper from assay: CFTR:liu-p2y2-isc-trachea-pm25

Statistical test: Student's t test

COMP:liu-p2y2-goblet-pm25-vs-ova

Goblet cell proportion, OVA+PM2.5 vs OVA

The proportion of PAS-positive goblet cells in the PM2.5 group was obviously higher than in the OVA group. Reported by non-parametric test with thresholds p < 0.05, p < 0.001 and p < 0.0001 marked on the figure; the paper gives no magnitude for the change.

measurement: goblet_cell_percentage direction: increased derivation: reported in paper from assay: GCM:liu-p2y2-pas-bronchus

Statistical test: non-parametric test

COMP:liu-p2y2-goblet-atp-vs-ova

Goblet cell proportion, OVA+ATP vs OVA

The proportion of PAS-positive goblet cells in ATP-treated OVA mice was evidently lower than in the OVA group - the rescue arm of the same experiment. Reported by non-parametric test; the paper gives no magnitude for the change.

measurement: goblet_cell_percentage direction: decreased derivation: reported in paper from assay: GCM:liu-p2y2-pas-bronchus

Statistical test: non-parametric test

COMP:liu-p2y2-sraw-pm25-vs-ova

Special airway resistance, OVA+PM2.5 vs OVA

sRaw in the PM2.5 group was significantly elevated over the OVA group across methacholine concentrations. Reported by one-way ANOVA with p < 0.05 marked against the OVA group; the paper gives no magnitude for the change.

measurement: lung_resistance direction: increased derivation: reported in paper from assay: LF:liu-p2y2-sraw-methacholine

Statistical test: one-way analysis of variance

COMP:liu-p2y2-sraw-suramin-vs-ova

Special airway resistance at 20 mg/mL methacholine, OVA+Suramin vs OVA

sRaw at 20 mg/mL methacholine in the Suramin+OVA group was higher than in the OVA group alone; the paper states the threshold P < 0.05 and no magnitude. This arm is the paper's evidence that blocking P2Y2R alone worsens airway responsiveness.

measurement: lung_resistance direction: increased derivation: reported in paper from assay: LF:liu-p2y2-sraw-methacholine

Statistical test: one-way analysis of variance

Key-event relationships

KER:liu-p2y2-p2y2r-to-calcium

Decreased P2Y2R expression leads to decreased intracellular calcium

ATP pre-treatment raised cytoplasmic free calcium in Calu-3 cells, and Suramin (a P2Y2R antagonist) or PM2.5 reduced the ATP-induced rise, which the paper reads as P2Y2R-dependent calcium mobilisation. Measured by Fluo-3/AM flow cytometry; the paper reports mean fluorescence intensity as figure bars only, so it is recorded here as a relationship rather than as an assay with a magnitude (the schema also has no calcium-mobilisation assay type).

The mean fluorescent intensity in the ATP group was significantly higher than that of the control group after 24 h and 48 h (p <0.01), but the fluorescent intensity in the ATP+PM2.5group were significantly lower than that of the ATP group (p < 0.01)
SUPPORT IN VITRO PMID:39113893

The flow cytometry result behind this relationship: ATP raised cytoplasmic calcium and PM2.5 suppressed that rise.

Our study demonstrated that PM2.5inhibited the release of ATP-induced cytoplasmic free calcium in the airway epithelial cells.
SUPPORT IN VITRO PMID:39113893

The authors' own statement of the downstream event in this relationship.

KER:liu-p2y2-calcium-to-cftr

Decreased intracellular calcium leads to decreased CFTR function

The paper concludes that PM2.5 inhibited the transepithelial anion Isc by downregulating the P2Y2R/CFTR pathway and the P2Y2/calcium-dependent chloride channel, and suggests that activation of calcium-dependent chloride channels participates in modulating transepithelial Isc.

In addition, PM2.5 exposure decreased the expression levels of P2Y2R, CFTR and cytoplasmic free-calcium, but ATP can increase the expressions of these proteins.
SUPPORT IN VITRO PMID:39113893

Places the calcium decrease alongside the CFTR decrease under the same exposure; the paper infers, but does not directly test, the causal step, hence weak support.

KER:liu-p2y2-p2y2r-to-cftr

Decreased P2Y2R expression leads to decreased CFTR function

The central mechanism of the paper: PM2.5 downregulates the P2Y2R/CFTR pathway and so impairs the ATP-induced transepithelial anion short-circuit current, in Calu-3 monolayers and in mouse tracheal tissue alike.

Together, our study reveals that PM2.5 impairs the ATP-induced transepithelial anion Isc through downregulating P2Y2R/CFTR pathway, and this process may participate in aggravating airway hyperresponsiveness and airway inflammation.
SUPPORT IN VITRO PMID:39113893

The paper's summary of this relationship and of the two downstream relationships recorded below.

KER:liu-p2y2-cftr-to-asl

Decreased CFTR function leads to decreased ASL

The ATP-induced anion current and the ASL volume fell together after PM2.5 exposure in the transwell model; the authors attribute the ASL loss to partial inhibition of the ATP-induced anion current, which is mainly controlled by CFTR.

In short, PM2.5exposures impaired the production of ASL and transepithelial anion Isc.
SUPPORT IN VITRO PMID:39113893

States that the same exposure impaired both the anion current and ASL production, the two events this relationship links.

KER:liu-p2y2-cftr-to-inflammation

Decreased CFTR function leads to airway inflammation

Decreased CFTR function (decreased) → indirectly leads to → Airway inflammation (increased) moderate support

The paper's in vivo arm: PM2.5 and Suramin, both of which lower P2Y2R/CFTR, raised Th2 cytokines in BALF, lung inflammation, collagen deposition and goblet cell hyperplasia, while ATP administration reduced lung inflammation in the asthma model.

PM2.5 exposure increased the levels of Th2-related cytokines of bronchoalveolar lavage fluid, lung inflammation, collagen deposition and hyperplasisa of goblet cells.
SUPPORT MODEL ORGANISM PMID:39113893

The inflammatory downstream event of this relationship, as stated in the abstract.

KER:liu-p2y2-inflammation-to-lung-function

Airway inflammation leads to decreased lung function

Airway inflammation (increased) → indirectly leads to → Decreased lung function (decreased) moderate support

sRaw rose in OVA mice over control and rose further with PM2.5, and rose at 20 mg/mL methacholine with Suramin; the paper concludes that impairing the ATP/P2Y2R pathway increases airway responsiveness alongside Th2 inflammatory factors.

The sRaw value in PM2.5group was significantly elevated than that in the OVA group.
SUPPORT MODEL ORGANISM PMID:39113893

The lung-function endpoint of this relationship: airway resistance rose further when PM2.5 was added to the OVA model.

Protocols

PROTOCOL:liu-p2y2-ussing-cell-001

Ussing chamber short-circuit current, Calu-3 monolayer

TER measured with an RE1600 epithelium resistor (Kingtech, Beijing). Monolayers loaded into an Ussing chamber (Kingtech, Beijing) with 5 mL K-H solution per side: solution A (NaCl 120 mM, NaHCO3 25 mM, KH2PO4 3.3 mM, K2HPO4 0.128 mM, MgCl2 1.2 mM, CaCl2 1.2 mM, mannitol 10 mM) on side A, solution B (mannitol replaced by glucose 10 mM) on side B. Agar-bridge current and voltage electrodes (1% agar in 3 M KCl). Chamber at 37 C, 95% oxygen / 5% carbon dioxide; an electrode was accepted only if the current exceeded 60 uA, and the A/B resistance difference was compensated to zero. Voltage clamped at zero; baseline Isc recorded once stable (up to 30 min), then ATP added to side A. Analysis of the response from baseline to peak: maximum difference (delta-Isc) and average rate (delta-Isc/delta-T).

quality control criteria: An electrode was accepted only when the current exceeded 60 uA; the resistance difference between solution A and solution B was compensated to zero; baseline Isc was recorded only once stable.

Equipment: Ussing chamber, electrophysiological detection equipment (Kingtech, Beijing); RE1600 epithelium resistor (Kingtech, Beijing); Agar-bridge current and voltage electrodes (1% agar in 3 M KCl); K-H solution A and solution B

PROTOCOL:liu-p2y2-ussing-trachea-001

Ussing chamber short-circuit current, mouse tracheal tissue

As for the Calu-3 protocol, with tissue in place of a monolayer: main trachea excised at 8 mm x 8 mm, held in saline to preserve viability, blood vessels and connective tissue removed, mounted on the tissue clip with K-H solution A to the luminal side and solution B to the basal side. The ATP concentration used to stimulate tissue was 100 uM rather than 10 uM.

Equipment: Ussing chamber, electrophysiological detection equipment (Kingtech, Beijing); Tissue clip

PROTOCOL:liu-p2y2-asl-001

Airway surface liquid volume on transwell inserts

At 100% confluency in transwell plates, 100 uL of medium containing ATP or PM2.5 was added per group; the control received 100 uL PBS. ASL volume was recovered from the chamber after 24 h with a pipette accurate to 0.01 uL. The experiment was repeated three times. The paper reports the resulting volumes only as figure bars, not as numbers.

replicate requirements: 3

Equipment: Transwell plates (3801, Corning); Pipette with 0.01 uL accuracy

PROTOCOL:liu-p2y2-qpcr-001

qRT-PCR for P2Y2R in Calu-3 cells

type: MolecularAssayProtocol

Total RNA extracted from Calu-3 cells by the TRIzol method (Sigma); cDNA synthesised with a reverse transcription kit (Takara, Dalian). GADPH used as internal control. Experiment repeated three times.

reference gene: GADPH replicate requirements: 3
PROTOCOL:liu-p2y2-wb-001

Western blot for P2Y2R and CFTR

type: MolecularAssayProtocol

RIPA lysate (Solarbio, Beijing) used to extract total protein from Calu-3 cells and from right lung tissue of mice; protein quantified with a BCA Protein Assay Kit (Beyotime). 40 ug per lane separated on 10% SDS-PAGE, transferred to PVDF (Millipore), blocked in 5% skim milk / TBS-T for 1.5 h. Bands observed on a ChemiScope series imager (Clinx, Shanghai) and analysed semi-quantitatively by densitometry. Experiment repeated three times.

detection method: Chemiluminescence, ChemiScope series (Clinx, Shanghai); semi-quantitative densitometry normalization method: GADPH loading control replicate requirements: 3
PROTOCOL:liu-p2y2-flowcyt-001

Fluo-3/AM flow cytometry for cytoplasmic free calcium

type: MolecularAssayProtocol

Calu-3 cells digested with EDTA-free trypsin and washed twice in calcium-free PBS. Each sample split in half; one half labelled with 0.5 uL Fluo-3/AM probe (Beyotime, Shanghai), the other kept as the unlabelled control. Incubated at 37 C for 30 min, washed twice in calcium-free PBS, resuspended in 400 uL PBS and incubated 20 min. FITC-channel fluorescence read on a BD Accuri C6 Plus flow cytometer; Fluo-3/AM excitation 488 nm, emission 525 nm. Mean fluorescence intensity analysed in FlowJo v10.0. Experiment repeated three times.

detection method: Flow cytometry, FITC channel, mean fluorescence intensity platform: BD Accuri C6 Plus replicate requirements: 3
PROTOCOL:liu-p2y2-ihc-001

Immunohistochemistry for P2Y2R and CFTR in lung tissue

type: StainingProtocol

Left lung fixed in 4% paraformaldehyde (Sigma) for 24 h, paraffin-embedded and cut at 5 um. Sections incubated with primary antibodies, washed in PBS, then incubated with mouse anti-rabbit IgG and a streptavidin peroxidase complex for 40 min at 37 C (ZSGB-BIO, Beijing). Expression quantified by staining intensity and expressed as the percentage of positive cells.

staining type: immunohistochemistry fixation method: 4% paraformaldehyde, 24 h detection method: 0.05% diaminobenzidine (DAB) substrate
PROTOCOL:liu-p2y2-pas-001

Periodic Acid-Schiff staining for goblet cells

type: StainingProtocol

Tissue slices (5 um) stained with Periodic Acid-Schiff to assess hyperplasia of goblet cells in the bronchus. PAS-stained cells counted as goblet cells; result expressed as the percentage of positive cells.

staining type: PAS fixation method: 4% paraformaldehyde, 24 h
PROTOCOL:liu-p2y2-elisa-001

ELISA for Th2 cytokines in mouse BALF

type: MolecularAssayProtocol

After isoflurane anaesthesia (RWD, Guangzhou) the left main bronchus was ligated with surgical thread; the right lung was washed twice with 0.5 mL saline and the lavage liquid collected. IL-4, IL-5 and IL-13 measured with mouse ELISA kits (Absin, Shanghai) per the manufacturer's instructions.

detection method: ELISA, mouse kits (Absin, Shanghai)
PROTOCOL:liu-p2y2-plethys-001

Whole-body plethysmography with methacholine challenge

type: SpirometryProtocol

Mice placed in a whole-body chamber connected to the BUXCO system (DSI, MN). Airway responsiveness expressed as special airway resistance (sRaw, cmH2O/mL/s), obtained with aerosols of methacholine at 0, 5, 10 and 20 mg/mL and analysed with FLexi Vent software.

spirometry standard: BUXCO whole-body plethysmography (DSI, MN) bronchodilator agent: methacholine aerosol challenge at 0, 5, 10 and 20 mg/mL plethysmography method: whole-body plethysmography